CIK 0001001250
- Large accelerated filer
ESTEE LAUDER COMPANIES INC
Sign in to watch- Ticker
- EL
- Exchange
- NYSE
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 112408943
- Phone
- +1 212-572-4200
- Business address
- 767 FIFTH AVE, NEW YORK, NY, 10153
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $25,135,334
- in 10 filings
Net −$25,135,334. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- FRIBOURG PAUL J −$20.4M Director sold 38% of stake
- La Lande Rashida −$2.4M Exec VP & General Counsel sold 100% of stake
- de la Faverie Stephane −$1.0M President and CEO sold 32% of stake
- STERNLICHT BARRY S −$510K Director sold 12% of stake
- Webster Meridith −$468K Exec VP GlobalComm/PubAffairs sold 100% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-07 | TRAVIS TRACEY THOMAS EVP & CFO | Exercise or conversion | +26,792 | $77.35 | $2.1M | 58,311 |
| 2021-05-07 | TRAVIS TRACEY THOMAS EVP & CFO | Sale | −26,792 | $305.01 | $8.2M | 31,339 |
| 2021-05-07 | TRAVIS TRACEY THOMAS EVP & CFO | Exercise or conversion · Option (Right to Buy) | −26,792 | 0 | ||
| 2021-05-07 | Demsey John Group President | Sale | −1,500 | $299.90 | $450K | 8,519 |
| 2021-05-05 | LAUDER RONALD S Chairman, Clinique Labs LLC | Sale | −1,700,000 | $292.00 | $496.4M | 0 |
| 2021-05-04 | LAUDER RONALD S Chairman, Clinique Labs LLC | Conversion | +1,700,000 | 1,700,000 | ||
| 2021-05-04 | LAUDER RONALD S Chairman, Clinique Labs LLC | Conversion · Class B Common Stock | −1,700,000 | 5,468,846 | ||
| 2021-05-04 | O'HARE MICHAEL EVP-Global Human Resources | Sale | −1,783 | $294.56 | $525K | 400 |
| 2021-05-04 | O'HARE MICHAEL EVP-Global Human Resources | Sale | −400 | $294.75 | $118K | 0 |
| 2021-05-04 | Demsey John Group President | Sale | −1,000 | $296.02 | $296K | 10,019 |
| 2021-05-04 | BARSHEFSKY CHARLENE Director | Exercise or conversion | +4,576 | $57.53 | $263K | 44,160 |
| 2021-05-04 | BARSHEFSKY CHARLENE Director | Sale | −910 | $293.54 | $267K | 43,250 |
| 2021-05-04 | BARSHEFSKY CHARLENE Director | Exercise or conversion · Option (Right to Buy) | −4,576 | 0 | ||
| 2021-04-19 | Canevari Roberto Executive Vice President | Grant or award · Option (Right to Buy) | +9,356 | 9,356 | ||
| 2021-04-19 | Canevari Roberto Executive Vice President | Grant or award · Restricted Stock Units (Share Payout) | +2,750 | 2,750 | ||
| 2021-04-19 | Canevari Roberto Executive Vice President | Grant or award · Restricted Stock Units (Share Payout) | +3,235 | 3,235 | ||
| 2021-04-09 | TRAVIS TRACEY THOMAS EVP & CFO | Exercise or conversion | +22,924 | $76.23 | $1.7M | 54,263 |
| 2021-04-09 | TRAVIS TRACEY THOMAS EVP & CFO | Sale | −22,924 | $300.01 | $6.9M | 31,339 |
| 2021-04-09 | TRAVIS TRACEY THOMAS EVP & CFO | Exercise or conversion · Option (Right to Buy) | −22,924 | 0 | ||
| 2021-04-09 | MOSS SARA E Vice Chairman | Exercise or conversion | +12,000 | $107.95 | $1.3M | 12,000 |
Page 74 of 89 · 1,779 trades